ABEONA THERAPEUTICS INC's ticker is and the CUSIP is 00289Y206. A total of 50 filers reported holding ABEONA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $324 | -20.8% | 76,394 | +35.5% | 0.00% | – |
| Q1 2024 | $409 | -51.9% | 56,394 | -66.8% | 0.00% | – |
| Q4 2023 | $850 | -45.7% | 169,732 | -54.3% | 0.00% | -100.0% |
| Q3 2023 | $1,564 | +109.1% | 371,276 | +100.0% | 0.00% | – |
| Q2 2023 | $748 | +43.0% | 185,638 | 0.0% | 0.00% | – |
| Q1 2023 | $523 | -8.6% | 185,638 | 0.0% | 0.00% | – |
| Q4 2022 | $572 | -94.8% | 185,638 | +4972.1% | 0.00% | – |
| Q3 2022 | $11,000 | – | 3,660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Standard LLC | 1,587,099 | $6,729,300 | 6.97% |
| Rosalind Advisors, Inc. | 1,750,000 | $7,420,000 | 5.71% |
| Propel Bio Management, LLC | 1,248,044 | $5,291,706 | 3.43% |
| Nantahala Capital Management | 3,470,037 | $14,712,956 | 0.86% |
| Vivo Capital, LLC | 1,842,751 | $7,813,264 | 0.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,685,503 | $15,626,533 | 0.57% |
| Ikarian Capital, LLC | 768,593 | $3,258,835 | 0.57% |
| Newtyn Management, LLC | 380,000 | $1,611,200 | 0.30% |
| 683 Capital Management, LLC | 600,000 | $2,544,000 | 0.19% |
| Nantahala Capital Management | 520,000 | $2,204,800 | 0.13% |